Used in combination with chemo, the immunotherapy drug Nivolumab has had promising results in treating tumors in advanced head and neck cancer patients.

As of Jan. 1, 2016, more than 15.5 million Americans have a history of cancer; in 2026, this number will reach more than 20 million.

Bristol-Myers Squibb's cancer immunotherapy drug, Opdivo, helped advanced head and neck cancer patients with a dismal prognosis live longer than other standard treatments, according to data from a late-stage study presented on Tuesday.

President Obama promised to undertake a national effort to cure cancer, a “new moonshot” with Vice President Biden in charge of “mission control.”

A compound found in broccoli may serve as natural treatment for cancer prevention.

A new study has identified four proteins that play a crucial role in drug-resistant HPV-negative head-and-neck squamous cell cancers, bringing hope to researchers seeking better drug targets.

The anticonvulsant and mood-stabilizing drug valproic acid is associated with a 34 percent lower risk of head and neck cancer, a new study finds.

Adults who continuously suffer from cavities may reduce their risk of head and neck cancer.